2016
DOI: 10.1111/vde.12289
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous adverse drug reaction in a dog associated with imepitoin

Abstract: Imepitoin may result in cutaneous adverse drug reactions in dogs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Hypotension may have developed without glucocorticoid administration because skin detachment resembled that in severe burn patients, who commonly develop SIRS. Indeed, an anti‐inflammatory dose of glucocorticoid was employed to manage cutaneous drug hypersensitivity to avoid the risk of SIRS in a previous study 14. However, the reported case had not developed systemic symptoms (skin lesion was limited to the lips and philtrum) as presented in our cases, so healing may have been achievable simply with removal of the offending drugs without administration of an immunosuppressive dose of glucocorticoid 17.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Hypotension may have developed without glucocorticoid administration because skin detachment resembled that in severe burn patients, who commonly develop SIRS. Indeed, an anti‐inflammatory dose of glucocorticoid was employed to manage cutaneous drug hypersensitivity to avoid the risk of SIRS in a previous study 14. However, the reported case had not developed systemic symptoms (skin lesion was limited to the lips and philtrum) as presented in our cases, so healing may have been achievable simply with removal of the offending drugs without administration of an immunosuppressive dose of glucocorticoid 17.…”
Section: Discussionmentioning
confidence: 69%
“…Different views on the efficacy of glucocorticoids for this disease have been reported, but rapid treatment with early tapering appears to have a role to play in effective immunosuppression without potential negative effects such as increased susceptibility to infection, interference with wound healing or increased mortality in humans 12 13. On the other hand, although successful use of these therapies has been seen in dogs with cutaneous drug hypersensitivity using anti‐inflammatory doses,14 little is known about the course of treatment with immunosuppressive dose for cutaneous drug hypersensitivity. Although we achieved successful outcomes in three cases with high doses for a short period, we cannot make any definitive statement regarding the efficacy of agents for the treatment of this disease based on these cases alone.…”
Section: Discussionmentioning
confidence: 99%
“…Cutaneous drug adverse reactions have been described in association with the use of various drugs, including meloxicam [23], imepitoin [24] and phenobarbital. Similar changes to drug adverse reactions can be also seen in chemical (photosensitivity) or contact dermatitis.…”
Section: Discussionmentioning
confidence: 99%
“…In humans, clinical signs vary from skin changes to cardiovascular changes or bronchospasm (5). In dogs, ADRs have been reported to present with skin changes and thrombocytopenia (6)(7)(8). Cutaneous ADR is an adverse drug reaction that appears on the skin first (2), and the lesions imitate any other skin disease (2,9,10).…”
Section: Introductionmentioning
confidence: 99%